ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

SUPER strength nicotine pouches being sold in the UK could put young people at risk of an accidental overdose, experts have ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

it won’t work if you have severe inflammation in your nose blocking the nasal passages. Smith suggests using a decongestant spray for no more than three days in a row to help shrink the swelling down, ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.

A randomized trial of nicotine nasal spray in adolescent smokers. Pediatrics. 2008 Sep;122(3):e595-600. doi: 10.1542/peds.2008-0501. PMID: 18762494; PMCID: PMC2744418. Anderer S. FDA Greenlights Nasal ...